recreational drugs

content keywords
The content title	Keyword(s)
High-risk drug use and new psychoactive substances	death \| new psychoactive substances (NPS) \| problem drug use \| recreational drugs \| synthetic stimulants
Health responses to new psychoactive substances	best practice \| emerging topics \| health effects \| injection \| new psychoactive substances (NPS) \| prevention \| prison \| problem drug use \| recreational drugs \| synthetic drugs \| synthetic stimulants \| treatment \| young people
European Drug Report 2015: Trends and Developments	alcohol \| amphetamines \| cannabis \| chemistry \| co-morbidity \| cocaine \| consumption rooms \| crime \| death \| demand \| drug-law offences \| environmental indicators \| epidemiology \| evaluation \| gender \| hallucinogens \| harm reduction \| health effects \| heroin \| HIV \| infectious diseases \| injecting \| key indicators \| law \| markets \| methodology \| new psychoactive substances (NPS) \| older people \| opioids \| overdose \| policy \| polydrug use \| prevalence \| prevention \| price \| prison \| problem drug use \| public expenditure \| purity \| recreational drugs \| Reitox \| research \| seizures \| social exclusion \| social reintegration \| spice \| statistics \| strategies \| substitution treatment \| supply \| synthetic stimulants \| trafficking \| treatment \| trends \| young people
2009 Annual report on the state of the drugs problem in Europe	amphetamines \| cannabis \| co-morbidity \| cocaine \| demand \| drug-law offences \| emcdda \| epidemiology \| evaluation \| hallucinogens \| harm reduction \| health effects \| heroin \| HIV \| infectious diseases \| injecting \| law \| markets \| new psychoactive substances (NPS) \| opioids \| overdose \| policy \| polydrug use \| prevalence \| prevention \| price \| prison \| problem drug use \| public expenditure \| purity \| recreational drugs \| research \| seizures \| social exclusion \| social reintegration \| spice \| strategies \| substitution treatment \| supply \| synthetic stimulants \| trafficking \| treatment \| trends
European Drug Report 2014: Trends and developments	amphetamines \| cannabis \| cocaine \| crime \| death \| demand \| drug-law offences \| harm reduction \| health effects \| heroin \| infectious diseases \| injecting \| key indicators \| markets \| new psychoactive substances (NPS) \| opioids \| overdose \| policy \| prevalence \| prevention \| price \| prison \| problem drug use \| recreational drugs \| seizures \| statistics \| strategies \| substitution treatment \| supply \| synthetic stimulants \| trafficking \| treatment \| trends \| young people
2010 Annual report on the state of the drugs problem in Europe	amphetamines \| cannabis \| co-morbidity \| cocaine \| crime \| death \| demand \| drug-law offences \| emcdda \| epidemiology \| gender \| hallucinogens \| health effects \| heroin \| HIV \| infectious diseases \| injecting \| key indicators \| law \| markets \| new psychoactive substances (NPS) \| opioids \| overdose \| policy \| polydrug use \| prevalence \| prevention \| price \| prison \| problem drug use \| public expenditure \| purity \| recreational drugs \| research \| seizures \| social exclusion \| social reintegration \| spice \| strategies \| substitution treatment \| supply \| synthetic stimulants \| trafficking \| treatment \| trends
EMCDDA–Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone)	new psychoactive substances (NPS) \| recreational drugs
EMCDDA–Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)	new psychoactive substances (NPS) \| recreational drugs
Emergency health consequences of cocaine use in Europe. A review of the monitoring of drug-related acute emergencies in 30 European countries	cocaine \| death \| epidemiology \| health effects \| key indicators \| new psychoactive substances (NPS) \| overdose \| prevalence \| recreational drugs
Driving Under the Influence of Drugs, Alcohol and Medicines in Europe — findings from the DRUID project	alcohol \| amphetamines \| cannabis \| cocaine \| death \| driving \| epidemiology \| evaluation \| law \| methodology \| policy \| polydrug use \| prevalence \| prevention \| recreational drugs \| research \| social reintegration \| statistics

content keywords

Keyword(s)

High-risk drug use and new psychoactive substances

death | new psychoactive substances (NPS) | problem drug use | recreational drugs | synthetic stimulants

Health responses to new psychoactive substances

European Drug Report 2015: Trends and Developments

2009 Annual report on the state of the drugs problem in Europe

European Drug Report 2014: Trends and developments

2010 Annual report on the state of the drugs problem in Europe

EMCDDA–Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone)

new psychoactive substances (NPS) | recreational drugs

EMCDDA–Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)

new psychoactive substances (NPS) | recreational drugs

Emergency health consequences of cocaine use in Europe. A review of the monitoring of drug-related acute emergencies in 30 European countries

Driving Under the Influence of Drugs, Alcohol and Medicines in Europe — findings from the DRUID project

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>

Contact

The EMCDDA is located at:
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact information >>

Feedback and support

The EMCDDA is an agency of the European Union.

About the EMCDDA

Follow us

Contact

Feedback and support